Peripheral Artery Disease

A risk score may be able to identify adults with type 2 diabetes at high risk for major adverse limb events, including in those without a history of peripheral artery disease, according to a study published in Diabetic Medicine.

Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a platform for percutaneous femoral-popliteal bypass for severe peripheral artery disease.

The FDA’s Circulatory System Devices Panel voted not to recommend approval of a drug-coated balloon to treat below-the-knee lesions in patients with critical limb ischemia.

At 5 years, there was no link between a paclitaxel-coated balloon and excess mortality compared with percutaneous transluminal angioplasty in two studies of patients with peripheral artery disease.

A vessel preparation system involving microincisions used before endovascular treatment for peripheral artery disease was associated with good outcomes at 1 year, researchers reported.

A low-dose paclitaxel-coated balloon was similar to a higher-dose paclitaxel-coated balloon in safety and efficacy among patients with femoropopliteal lesions at 2 years, according to new data from the COMPARE trial.

The first thing she asked was, “Is my husband going to get to come?”

An interim analysis of the SWEDEPAD trial, which was paused after a meta-analysis detected a mortality hazard associated with paclitaxel-coated devices, found no death risk from the devices in patients with peripheral artery disease.

Healio and Cardiology Today have aggregated the most-read news from the virtual VIVA 20.

Penumbra announced its aspiration system to treat pulmonary embolism has received clearance for an expanded indication from the FDA.